Entrada Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Entrada Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE) (NCT07682129) | Entrada Therapeutics, Inc. | 2026-08-01 |
| A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45 (NCT07038824) | Entrada Therapeutics, Inc. | 2025-08-30 |
| A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44 (NCT07037862) | Entrada Therapeutics, Inc. | 2025-06-30 |
| Natural History Study of MNGIE (NCT04245917) | Entrada Therapeutics, Inc. | 2020-08-06 |
Track Entrada Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.